| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $557,317.93 | $574,037.47 | $1,612,960.00 | |
Aetna
| Professional | $557,317.93 | $562,891.11 | $654,925.00 |
Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $557,317.93 | $574,037.47 | $1,612,960.00 | |
Aetna
| Professional | $557,317.93 | $562,891.11 | $654,925.00 |